Filing Flows › Codexis (CDXS) › Q2 2026 › vs Q1 2026
Codexis (CDXS) Q2 2026 vs Q1 2026 (quarter over quarter)
Codexis's revenue fell $333K (-2%) from $15.2M in Q1 2026 to $14.9M in Q2 2026. The biggest changes: Research and development revenue −$6.4M (-79%); Product revenue +$6.0M (+84%).
Codexis, Q2 2026: revenue $14.9M (-3% year over year), operating margin -75.3%, net loss $12.0M, operating cash flow −$9.6M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product revenue | $13.2M | $7.2M | $6.0M | +84% |
| Research and development revenue | $1.7M | $8.1M | −$6.4M | -79% |
| Revenue | $14.9M | $15.2M | −$333K | -2% |
| Net loss | $12.0M | $8.7M | $3.3M | +38% |
| Costs & expenses | $26.9M | $24.0M | $3.0M | +12% |
| Operating costs | $26.1M | $23.3M | $2.9M | +12% |
| Interest & other, net | $766K | $625K | $141K | +23% |
| Income tax | $10K | $36K | −$26K | -72% |
| Cost of revenue | $3.5M | $2.1M | $1.4M | +70% |
| Research & development | $11.7M | $11.4M | $257K | +2% |
| SG&A | $10.9M | $9.8M | $1.1M | +12% |
| Operating cash sources | $12.4M | $15.9M | −$3.4M | -22% |
| Depreciation & amortization | $1.2M | $1.3M | −$76K | -6% |
| Share-based compensation | $1.6M | $1.4M | $155K | +11% |
| Cash used in operations | $9.6M | $13.2M | −$3.5M | -27% |
| Net loss absorbed | $12.0M | $8.7M | $3.3M | +38% |
| Working capital & other | $431K | $7.2M | −$6.7M | -94% |
Questions
How much did Codexis's revenue grow quarter over quarter in Q2 2026?
Codexis's revenue fell $333K (-2%) from $15.2M in Q1 2026 to $14.9M in Q2 2026.
What drove Codexis's revenue change in Q2 2026?
Research and development revenue −$6.4M (-79%); Product revenue +$6.0M (+84%).